Page 4 - Jay Luly News Today : Breaking News, Live Updates & Top Stories | Vimarsana

03.01.21 -- Enanta Pharmaceuticals: From Failure To Formidable   Cidara Therapeutics President and CEO Dr. Jeff Stein joins the Business of Biotech to discuss his career mission to battle microbial organisms and his company's development of a novel approach to producing immunotherapeutic antivirals that couple potent antivirals to a human antibody fragment. Listen now and subscribe so you never miss an episode. Featured Articles   IBM and GE are some famous business-focused turnaround stories, but this month we’ve got a memorable one from the biopharma i...

A Behind The Scenes Look Into Enanta's CEO, Jay Luly Source: Life Science Leader Follow Me On Twitter @RfwrightLSL Jay Luly, Ph.D., president and CEO, Enanta Pharmaceuticals “I grew up in Illinois,” shares Jay Luly, Ph.D., CEO of Enanta Pharmaceuticals. Luly is being interviewed for a future feature in Life Science Leader, and I started the conversation with a little ice breaker. Luly shares that somewhere along the way in high school, he figured out he wanted to study chemistry. Turns out the University of Illinois (U of I) had one of the strongest chemistry departments in the country a...

Operator Good afternoon, and welcome to Enanta Pharmaceuticals First Quarter 2021 Financial Results Conference Call. [Operator Instructions] There will be a question-and-answer session at the end of the prepared remarks. [Operator Instructions] I would now like to turn the conference over to Jennifer Viera, Investor Relations. Please go ahead. Jennifer Viera -- Investor Relations Thank you, operator, and thank you to everyone for joining us this afternoon. The news release with our fiscal first quarter financial results was issued this afternoon and is available on our website. On the call t...